NAPI comprises partners from all Norwegian proteomics core facilities, as well as research groups from across Norway with a strong focus on proteomics technology development. Details of individual partners and their areas of expertise are provided below.
Dr Tuula Nyman is the NAPI Project Manager, based at the Institute for Clinical Medicine, Faculty of Medicine, UiO, and is also the head of the Proteomics Core Facilty at Oslo University Hospital. Dr Nyman's own research focuses on applying proteomics to immunology and clinical studies.
Dr Bernd Thiede is the head of the Proteomics Core Facility at the Department of Biosciences, Faculty of Mathematics and Natural Sciences, UiO. Dr Thiede has extensive proteomics research experience, and specializes in developing analytical proteomics techniques to study the biology of cancer.
Professor Frode Berven has been head of the Proteomics Unit at UiB (PROBE) since 2009, and has been working with proteomics since 1999. Dr Berven's main experience has been in quantitative proteomics and related bioinformatics, with a particular focus on clinical samples.
Professor Geir Slupphaug is the leader of the Proteomics and Modomics Experimental Core (PROMEC) at NTNU. Professor Slupphaug's own research focuses on structural/functional studies related to mammalian genome maintenance, as well as protein biomarkers in human disease.
Professor Vincent Eijsink is the board leader at the MS and Proteomics Core Facility, NMBU. His research focuses on the production and characterization of proteins and enzymes, as well as their applications in contexts such as biomass processing, microbial ecology and bacterial pathogenicity.
Professor Steven Ray Wilson is an expert in analytical chemistry based at the Department of Chemistry, University of Oslo. Professor Wilson's main focus is the application of omics approaches for supporting early-stage diagnostics and personalized medicine.
Professor Trine Grønhaug Halvorsen is based at the Department of Pharmacy, UiO, where she is a leader of the Smart Protein Analysis Group. She has broad experience in developing new strategies for targeted analysis of protein biomarkers in biological matrices by mass spectrometry.
Professor Jens Pahnke is based at the Department of Pathology, UiO and OUS. He is an expert in diagnostic pathology/neuropathology and in translational dementia research. Professor Pahnke's research and diagnostic lab was established in Norway in 2014. The group has a focus on using imaging mass spectrometry for disease diagnoses.
Dr Fridtjof Lund-Johansen is a principal investigator at the Department of Immunology, OUS-Rikshospitalet where he leads the Protein Array Group and the Flow Cytometry Core Facility. His main research interests include antibody validation, MHC-peptide complexes, subcellular proteomics and array-based proteomics.
Professor Terje Johansen is the head of the Tromsø University Proteomics Platform, and group leader at the Department of Medical Biology, Faculty of Health Sciences, UiT. His research group uses proteomics approaches to study autophagy proteins, with a focus on interactomics and PTMs.
Dr Magnus Ø. Arntzen is based at the Faculty of Chemistry, Biotechnology and Food Science at NMBU. He has worked with proteomics and bioinformatics solutions for 15 years, focusing on metaproteomics of microbial communities and integration with other multi-omics data.
Professor Léon Reubsaet is based at the Department of Pharmacy, UiO, and has more than 25 years’ experience in mass spectrometric determination of biologically active compounds in complex samples. He is a leader of the Smart Protein Analysis Group at UiO, which aims to improve targeted protein analysis using smart sampling technology.